Read all posts
www.healthline.com

Long-Term Study of Gilenya Shows Positive Results in MS Treatment

The results of the study involving 1,600 patients continue to highlight Gilenya's safety profile and ability to reduce multiple sclerosis relapse rates. A long-term study of the drug Gilenya shows the medication to be consistently effective in treating multiple sclerosis (MS) without any new side effects.

Read the article on Healthline

Dr. Sears Comments:

Dr. Barry Sears

Whatever happened to double-blind, placebo-controlled trials that are the basis of evidence-based medicine.  Comparing two relatively weak drugs without including a placebo arm for both is pathetic research.

 

Leave a Reply

Your email address will not be published. Required fields are marked *